1,3,8-trihydroxyeudesm-4-en-7alpha,11betaH-12,6alpha-olide - Compound Card

1,3,8-trihydroxyeudesm-4-en-7alpha,11betaH-12,6alpha-olide

Select a section from the left sidebar

1,3,8-trihydroxyeudesm-4-en-7alpha,11betaH-12,6alpha-olide

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Benzouran
Canonical Smiles O[C@H]1C[C@@]2(C)[C@H](O)C[C@H](C(=C2[C@@H]2[C@@H]1[C@@H](C)C(=O)O2)C)O
InChI InChI=1S/C15H22O5/c1-6-8(16)4-10(18)15(3)5-9(17)11-7(2)14(19)20-13(11)12(6)15/h7-11,13,16-18H,4-5H2,1-3H3/t7-,8-,9+,10-,11-,13+,15+/m1/s1
InChIKey WPMPEWUQMJTEGS-JVIIBZDWSA-N
Formula C15H22O5
HBA 5
HBD 3
MW 282.34
Rotatable Bonds 0
TPSA 86.99
LogP 0.38
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 20
Formal Charge 0
Fraction CSP3 0.8
Exact Mass 282.15
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Artemisia herba-alba Asteraceae Plantae 72329

Showing of synonyms

  • Mohamed T.A, Abd El Aty A.A, et al. (2021). New antimicrobial metabolites from the medicinal herb Artemisia herba-Alba. Natural product research, 2021, 35(12), 1959-1967. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1C(=O)OC(C12)C=3C(CC2)CCCC3

Level: 0

Mol. Weight: 282.34 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.86
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.47
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.04

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.49
Plasma Protein Binding
40.11
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
3.89
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.86
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.25
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-3.24
Rat (Acute)
2.87
Rat (Chronic Oral)
2.27
Fathead Minnow
3.53
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Toxic

General Properties

Boiling Point
378.47
Hydration Free Energy
-11.84
Log(D) at pH=7.4
0.11
Log(P)
-0.11
Log S
-1.36
Log(Vapor Pressure)
-7.46
Melting Point
181.83
pKa Acid
8.48
pKa Basic
5.49
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Androgen receptor P10275 ANDR_HUMAN Homo sapiens 3 0.7370
Androgen receptor P10275 ANDR_HUMAN Homo sapiens 3 0.7328
Sulfotransferase 2A1 Q06520 ST2A1_HUMAN Homo sapiens 2 0.7002

Download SDF